{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:30:47Z","timestamp":1792089047524,"version":"4.4.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41585-025-01069-9","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:24:34Z","timestamp":1759933474000},"page":"826-845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An update on mechanisms and treatment options for priapism"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5703-2319","authenticated-orcid":false,"given":"Karl H.","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6364-0310","authenticated-orcid":false,"given":"Hussain M.","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2958-1614","authenticated-orcid":false,"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"1069_CR1","unstructured":"Salonia A., et al. European Association of Urology 2025 guidelines: sexual and reproductive health. EAU Guidelines https:\/\/uroweb.org\/guidelines\/sexual-and-reproductive-health (2025)."},{"key":"1069_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.urology.2018.04.029","volume":"118","author":"S Vreugdenhil","year":"2018","unstructured":"Vreugdenhil, S., de Jong, I. J. & van Driel, M. F. Priapism throughout the ages. Urology 118, 21\u201324 (2018).","journal-title":"Urology"},{"key":"1069_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","volume":"57","author":"IA Eland","year":"2001","unstructured":"Eland, I. A., Van der Lei, J., Stricker, B. H. C. & Sturkenboom, M. J. C. M. Incidence of priapism in the general population. Urology 57, 970\u2013972 (2001).","journal-title":"Urology"},{"key":"1069_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/00365599509180545","volume":"29","author":"RV Kulmala","year":"1995","unstructured":"Kulmala, R. V., Lehtonen, T. A. & Tammela, T. L. J. Priapism, its incidence and seasonal distribution in Finland. Scand. J. Urol. Nephrol. 29, 93\u201396 (1995).","journal-title":"Scand. J. Urol. Nephrol."},{"key":"1069_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ijir.2011.7","volume":"23","author":"T Sugihara","year":"2011","unstructured":"Sugihara, T. et al. Incidence and clinical features of priapism in Japan: 46 cases from the Japanese diagnosis procedure combination database 2006\u20132008. Int. J. Impot. Res. 23, 76\u201380 (2011).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41443-022-00590-4","volume":"36","author":"M G\u00fcl","year":"2024","unstructured":"G\u00fcl, M. et al. What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU sexual and reproductive health guidelines panel. Int. J. Impot. Res. 36, 20\u201335 (2024).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","volume":"7","author":"GA Broderick","year":"2010","unstructured":"Broderick, G. A. et al. Priapism: pathogenesis, epidemiology, and management. J. Sex. Med. 7, 476\u2013500 (2010).","journal-title":"J. Sex. Med."},{"key":"1069_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/pgmj.2005.037291","volume":"82","author":"J Cherian","year":"2006","unstructured":"Cherian, J. et al. Medical and surgical management of priapism. Postgrad. Med. J. 82, 89 (2006).","journal-title":"Postgrad. Med. J."},{"key":"1069_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpurol.2013.07.024","volume":"10","author":"JF Donaldson","year":"2014","unstructured":"Donaldson, J. F., Rees, R. W. & Steinbrecher, H. A. Priapism in children: a comprehensive review and clinical guideline. J. Pediatr. Urol. 10, 11\u201324 (2014).","journal-title":"J. Pediatr. Urol."},{"key":"1069_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41443-024-00929-z","volume":"37","author":"K Almekaty","year":"2025","unstructured":"Almekaty, K. et al. The relationship between Coronavirus disease-19 (COVID-19) and ischemic priapism: a case-control study. Int. J. Impot. Res. 37, 372\u2013376 (2025).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR11","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jsxm.2020.05.019","volume":"17","author":"ME Rezaee","year":"2020","unstructured":"Rezaee, M. E. & Gross, M. S. Are we overstating the risk of priapism with oral phosphodiesterase type 5 inhibitors? J. Sex. Med. 17, 1579\u20131582 (2020).","journal-title":"J. Sex. Med."},{"key":"1069_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41443-019-0141-z","volume":"32","author":"M James Johnson","year":"2020","unstructured":"James Johnson, M. et al. Which patients with ischaemic priapism require further investigation for malignancy? Int. J. Impot. Res. 32, 195\u2013200 (2020).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.sxmr.2019.11.002","volume":"9","author":"O Ralph","year":"2021","unstructured":"Ralph, O., Shroff, N., Johnson, M. J., AlNajjar, H. M. & Ralph, D. Malignancy: a rare, important and poorly understood cause of priapism. Sex. Med. Rev. 9, 312\u2013319 (2021).","journal-title":"Sex. Med. Rev."},{"key":"1069_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0022-5347(17)58497-9","volume":"117","author":"JH Nelson","year":"1977","unstructured":"Nelson, J. H. & Winter, C. C. Priapism: evolution of management in 48 patients in a 22-year series. J. Urol. 117, 455\u2013458 (1977).","journal-title":"J. Urol."},{"key":"1069_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"TF Lue","year":"2000","unstructured":"Lue, T. F. Erectile dysfunction. N. Engl. J. Med. 342, 1802\u20131813 (2000).","journal-title":"N. Engl. J. Med."},{"key":"1069_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/1389450115666141111111842","volume":"16","author":"U Anele","year":"2014","unstructured":"Anele, U., Morrison, B. & Burnett, A. Molecular pathophysiology of priapism: emerging targets. Curr. Drug. Targets 16, 474\u2013483 (2014).","journal-title":"Curr. Drug. Targets"},{"key":"1069_CR17","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0407183102","volume":"102","author":"HC Champion","year":"2005","unstructured":"Champion, H. C., Bivalacqua, T. J., Takimoto, E., Kass, D. A. & Burnett, A. L. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc. Natl Acad. Sci. USA 102, 1661\u20131666 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1069_CR18","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.eururo.2006.10.061","volume":"51","author":"TJ Bivalacqua","year":"2007","unstructured":"Bivalacqua, T. J., Liu, T., Musicki, B., Champion, H. C. & Burnett, A. L. Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. Eur. Urol. 51, 1732\u20131740 (2007).","journal-title":"Eur. Urol."},{"key":"1069_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrurol.2014.278","volume":"11","author":"NA Sopko","year":"2014","unstructured":"Sopko, N. A., Hannan, J. L. & Bivalacqua, T. J. Understanding and targeting the Rho kinase pathway in erectile dysfunction. Nat. Rev. Urol. 11, 622\u2013628 (2014).","journal-title":"Nat. Rev. Urol."},{"key":"1069_CR20","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1111\/j.1743-6109.2009.01359.x","volume":"6","author":"TJ Bivalacqua","year":"2009","unstructured":"Bivalacqua, T. J. et al. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J. Sex. Med. 6, 2494\u20132504 (2009).","journal-title":"J. Sex. Med."},{"key":"1069_CR21","doi-asserted-by":"publisher","first-page":"510.e7","DOI":"10.1016\/j.urology.2010.02.050","volume":"76","author":"TJ Bivalacqua","year":"2010","unstructured":"Bivalacqua, T. J. et al. Attenuated RhoA\/Rho-kinase signaling in penis of transgenic sickle cell mice. Urology 76, 510.e7\u2013510.e12 (2010).","journal-title":"Urology"},{"key":"1069_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","volume":"189","author":"G Lagoda","year":"2013","unstructured":"Lagoda, G., Sezen, S. F., Cabrini, M. R., Musicki, B. & Burnett, A. L. Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis. J. Urol. 189, 762\u2013768 (2013).","journal-title":"J. Urol."},{"key":"1069_CR23","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/JCI33467","volume":"118","author":"T Mi","year":"2008","unstructured":"Mi, T. et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J. Clin. Invest. 118, 1491\u20131501 (2008).","journal-title":"J. Clin. Invest."},{"key":"1069_CR24","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1111\/j.1743-6109.2009.01552.x","volume":"7","author":"J Wen","year":"2010","unstructured":"Wen, J. et al. Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism. J. Sex. Med. 7, 3011\u20133022 (2010).","journal-title":"J. Sex. Med."},{"key":"1069_CR25","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1096\/fj.13-248708","volume":"28","author":"S Fu","year":"2014","unstructured":"Fu, S., Tar, M. T., Melman, A. & Davies, K. P. Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells. FASEB J. 28, 3633\u20133644 (2014).","journal-title":"FASEB J."},{"key":"1069_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1464-410X.2006.06247.x","volume":"98","author":"Y Tong","year":"2006","unstructured":"Tong, Y. et al. Variable coding sequence protein A1 as a marker for erectile dysfunction. BJU Int. 98, 396\u2013401 (2006).","journal-title":"BJU Int."},{"key":"1069_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.juro.2007.03.004","volume":"178","author":"Y Tong","year":"2007","unstructured":"Tong, Y. et al. hSMR3A as a marker for patients with erectile dysfunction. J. Urol. 178, 338\u2013343 (2007).","journal-title":"J. Urol."},{"key":"1069_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1464-410X.2008.07631.x","volume":"102","author":"Y Tong","year":"2008","unstructured":"Tong, Y., Tar, M., Melman, A. & Davies, K. The opiorphin gene (ProL1) and its homologues function in erectile physiology. BJU Int. 102, 736\u2013740 (2008).","journal-title":"BJU Int."},{"key":"1069_CR29","doi-asserted-by":"publisher","first-page":"C916","DOI":"10.1152\/ajpcell.00656.2008","volume":"297","author":"ND Kanika","year":"2009","unstructured":"Kanika, N. D. et al. The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. Am. J. Physiol. Cell Physiol. 297, C916\u2013C927 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1069_CR30","doi-asserted-by":"publisher","first-page":"H1340","DOI":"10.1152\/ajpheart.00121.2005","volume":"292","author":"TJ Bivalacqua","year":"2007","unstructured":"Bivalacqua, T. J., Burnett, A. L., Hellstrom, W. J. G. & Champion, H. C. Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am. J. Physiol. Heart Circ. Physiol. 292, H1340\u2013H1351 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1069_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","volume":"24","author":"B Musicki","year":"2020","unstructured":"Musicki, B. & Burnett, A. L. Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape. Expert. Opin. Ther. Targets 24, 439\u2013450 (2020).","journal-title":"Expert. Opin. Ther. Targets"},{"key":"1069_CR32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1440-1681.2007.04639.x","volume":"34","author":"KC Wood","year":"2007","unstructured":"Wood, K. C. & Granger, D. N. Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin. Exp. Pharmacol. Physiol. 34, 926\u2013932 (2007).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1069_CR33","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1210\/en.2003-1699","volume":"145","author":"A Morelli","year":"2004","unstructured":"Morelli, A. et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 145, 2253\u20132263 (2004).","journal-title":"Endocrinology"},{"key":"1069_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11255-014-0864-1","volume":"47","author":"BF Morrison","year":"2015","unstructured":"Morrison, B. F. et al. Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease? Int. Urol. Nephrol. 47, 47\u201352 (2015).","journal-title":"Int. Urol. Nephrol."},{"key":"1069_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/bju.15370","volume":"127","author":"GA Joice","year":"2021","unstructured":"Joice, G. A., Liu, J. L. & Burnett, A. L. Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm. BJU Int. 127, 498\u2013506 (2021).","journal-title":"BJU Int."},{"key":"1069_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.23736\/S0393-2249.19.03323-X","volume":"72","author":"G Liguori","year":"2020","unstructured":"Liguori, G. et al. The management of stuttering priapism. Minerva Urol. Nefrol. 72, 173\u2013186 (2020).","journal-title":"Minerva Urol. Nefrol."},{"key":"1069_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/aja.2011.114","volume":"14","author":"HR Levey","year":"2012","unstructured":"Levey, H. R., Kutlu, O. & Bivalacqua, T. J. Medical management of ischemic stuttering priapism: a contemporary review of the literature. Asian J. Androl. 14, 156\u2013163 (2012).","journal-title":"Asian J. Androl."},{"key":"1069_CR38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.2047-2927.2013.00084.x","volume":"1","author":"BF Morrison","year":"2013","unstructured":"Morrison, B. F., Reid, M., Madden, W. & Burnett, A. L. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Andrology 1, 576\u2013582 (2013).","journal-title":"Andrology"},{"key":"1069_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-2141.2007.06560.x","volume":"137","author":"L Elliott","year":"2007","unstructured":"Elliott, L. et al. Genetic polymorphisms associated with priapism in sickle cell disease. Br. J. Haematol. 137, 262\u2013267 (2007).","journal-title":"Br. J. Haematol."},{"key":"1069_CR40","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jsxm.2019.09.012","volume":"16","author":"M Cintho Ozahata","year":"2019","unstructured":"Cintho Ozahata, M. et al. Clinical and genetic predictors of priapism in sickle cell disease: results from the recipient epidemiology and donor evaluation study III Brazil cohort study. J. Sex. Med. 16, 1988\u20131999 (2019).","journal-title":"J. Sex. Med."},{"key":"1069_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.21037\/tau.2017.01.18","volume":"6","author":"M Hudnall","year":"2017","unstructured":"Hudnall, M., Reed-Maldonado, A. B. & Lue, T. F. Advances in the understanding of priapism. Transl. Androl. Urol. 6, 199\u2013206 (2017).","journal-title":"Transl. Androl. Urol."},{"key":"1069_CR42","first-page":"9","volume":"6","author":"GA Broderick","year":"1994","unstructured":"Broderick, G. A. & Harkaway, R. Pharmacologic erection: time-dependent changes in the corporal environment. Int. J. Impot. Res. 6, 9\u201316 (1994).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR43","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/j.1743-6109.2008.00862.x","volume":"5","author":"A Muneer","year":"2008","unstructured":"Muneer, A., Minhas, S., Freeman, A., Kumar, P. & Ralph, D. J. Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism. J. Sex. Med. 5, 2152\u20132159 (2008).","journal-title":"J. Sex. Med."},{"key":"1069_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0022-5347(17)45549-2","volume":"135","author":"MA Spycher","year":"1986","unstructured":"Spycher, M. A. & Hauri, D. The ultrastructure of the erectile tissue in priapism. J. Urol. 135, 142\u2013147 (1986).","journal-title":"J. Urol."},{"key":"1069_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bju.14140","volume":"121","author":"A Muneer","year":"2018","unstructured":"Muneer, A. et al. BAUS consensus document for the management of male genital emergencies: priapism. BJU Int. 121, 835\u2013839 (2018).","journal-title":"BJU Int."},{"key":"1069_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/JU.0000000000002767","volume":"208","author":"TJ Bivalacqua","year":"2022","unstructured":"Bivalacqua, T. J. et al. The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA\/SMSNA guideline. J. Urol. 208, 43\u201352 (2022).","journal-title":"J. Urol."},{"key":"1069_CR47","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/JU.0000000000002236","volume":"206","author":"TJ Bivalacqua","year":"2021","unstructured":"Bivalacqua, T. J. et al. Acute ischemic priapism: an AUA\/SMSNA guideline. J. Urol. 206, 1114\u20131121 (2021).","journal-title":"J. Urol."},{"key":"1069_CR48","doi-asserted-by":"publisher","first-page":"611.e9","DOI":"10.1016\/j.crad.2017.02.021","volume":"72","author":"C von Stempel","year":"2017","unstructured":"von Stempel, C. et al. Mean velocity and peak systolic velocity can help determine ischaemic and non-ischaemic priapism. Clin. Radiol. 72, 611.e9\u2013611.e16 (2017).","journal-title":"Clin. Radiol."},{"key":"1069_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/S41443-024-00928-0","author":"C von Stempel","year":"2024","unstructured":"von Stempel, C., Walkden, M. & Kirkham, A. Review of the role of imaging in the diagnosis of priapism. Int. J. Impot. Res. https:\/\/doi.org\/10.1038\/S41443-024-00928-0 (2024).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR50","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/j.1464-410X.2010.09368.x","volume":"106","author":"DJ Ralph","year":"2010","unstructured":"Ralph, D. J. et al. The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism. BJU Int. 106, 1714\u20131718 (2010).","journal-title":"BJU Int."},{"key":"1069_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41443-022-00592-2","volume":"36","author":"P Capogrosso","year":"2024","unstructured":"Capogrosso, P. et al. Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU sexual and reproductive health panel. Int. J. Impot. Res. 36, 6\u201319 (2024).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0022-5347(17)37781-9","volume":"146","author":"A Dittrich","year":"1991","unstructured":"Dittrich, A., Albrecht, K., Bar-Moshe, O. & Vandendris, M. Treatment of pharmacological priapism with phenylephrine. J. Urol. 146, 323\u2013324 (1991).","journal-title":"J. Urol."},{"key":"1069_CR53","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0018578718778230","volume":"54","author":"RDR Palagiri","year":"2019","unstructured":"Palagiri, R. D. R., Chatterjee, K., Jillella, A. & Hammond, D. A. A case report of hypertensive emergency and intracranial hemorrhage due to intracavernosal phenylephrine. Hosp. Pharm. 54, 186\u2013189 (2019).","journal-title":"Hosp. Pharm."},{"key":"1069_CR54","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1743-6109.2006.00281.x","volume":"3","author":"TF Lue","year":"2006","unstructured":"Lue, T. F. & Pescatori, E. S. Distal cavernosum-glans shunts for ischemic priapism. J. Sex. Med. 3, 749\u2013752 (2006).","journal-title":"J. Sex. Med."},{"key":"1069_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1743-6109.2012.02707.x","volume":"10","author":"AL Burnett","year":"2013","unstructured":"Burnett, A. L. & Sharlip, I. D. Standard operating procedures for priapism. J. Sex. Med. 10, 180\u2013194 (2013).","journal-title":"J. Sex. Med."},{"key":"1069_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41443-022-00604-1","volume":"36","author":"U Milenkovic","year":"2024","unstructured":"Milenkovic, U. et al. Surgical and minimally invasive treatment of ischaemic and non-ischaemic priapism: a systematic review by the EAU sexual and reproductive health guidelines panel. Int. J. Impot. Res. 36, 36\u201349 (2024).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR57","first-page":"5","volume":"32","author":"R Quackels","year":"1964","unstructured":"Quackels, R. Treatment of a case of priapism by cavernospongious anastomosis. Acta Urol. Belg. 32, 5\u201313 (1964).","journal-title":"Acta Urol. Belg."},{"key":"1069_CR58","doi-asserted-by":"publisher","first-page":"657","DOI":"10.21037\/tau.2017.07.23","volume":"6","author":"AB Reed-Maldonado","year":"2017","unstructured":"Reed-Maldonado, A. B., Kim, J. S. & Lue, T. F. Avoiding complications: surgery for ischemic priapism. Transl. Androl. Urol. 6, 657\u2013665 (2017).","journal-title":"Transl. Androl. Urol."},{"key":"1069_CR59","first-page":"509","volume":"1","author":"JT Grayhack","year":"1964","unstructured":"Grayhack, J. T., Mccullough, W., O\u2019Conor, V. J. & Trippel, O. Venous bypass to control priapism. Invest. Urol. 1, 509\u2013513 (1964).","journal-title":"Invest. Urol."},{"key":"1069_CR60","first-page":"316","volume":"2","author":"TF Lue","year":"2013","unstructured":"Lue, T. F. & Garcia, M. Should perioperative anticoagulation be an integral part of the priapism shunting procedure? Transl. Androl. Urol. 2, 316\u2013320 (2013).","journal-title":"Transl. Androl. Urol."},{"key":"1069_CR61","first-page":"241","volume":"8","author":"J Ebbeh\u00f8j","year":"1974","unstructured":"Ebbeh\u00f8j, J. A new operation for priapism. Scand. J. Plast. Reconstr. Surg. 8, 241\u2013242 (1974).","journal-title":"Scand. J. Plast. Reconstr. Surg."},{"key":"1069_CR62","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0090-4295(76)90498-2","volume":"8","author":"CC Winter","year":"1976","unstructured":"Winter, C. C. Cure of idiopathic priapism: new procedure for creating fistula between glans penis and corpora cavernosa. Urology 8, 389\u2013391 (1976).","journal-title":"Urology"},{"key":"1069_CR63","first-page":"1","volume":"2025","author":"M Gannon","year":"2025","unstructured":"Gannon, M. et al. Surgical illustrative review of the treatment of ischaemic priapism. Int. J. Impot. Res. 2025, 1\u20136 (2025).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR64","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0022-5347(17)58998-3","volume":"116","author":"JM Barry","year":"1976","unstructured":"Barry, J. M. Priapism: treatment with corpus cavernosum to dorsal vein of penis shunts. J. Urol. 116, 754\u2013756 (1976).","journal-title":"J. Urol."},{"key":"1069_CR65","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0022-5347(17)54971-X","volume":"125","author":"CJJ Ercole","year":"1981","unstructured":"Ercole, C. J. J., Pontes, J. E. & Pierce, J. M. Changing surgical concepts in the treatment of priapism. J. Urol. 125, 210\u2013211 (1981).","journal-title":"J. Urol."},{"key":"1069_CR66","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.juro.2008.12.021","volume":"181","author":"WO Brant","year":"2009","unstructured":"Brant, W. O., Garcia, M. M., Bella, A. J., Chi, T. & Lue, T. F. T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J. Urol. 181, 1699\u20131705 (2009).","journal-title":"J. Urol."},{"key":"1069_CR67","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1743-6109.2008.01176.x","volume":"6","author":"AL Burnett","year":"2009","unstructured":"Burnett, A. L. & Pierorazio, P. M. Corporal \u201csnake\u201d maneuver: corporoglanular shunt surgical modification for ischemic priapism. J. Sex. Med. 6, 1171\u20131176 (2009).","journal-title":"J. Sex. Med."},{"key":"1069_CR68","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/jsxmed\/qdae078","volume":"21","author":"S Unal","year":"2024","unstructured":"Unal, S., Karakus, S., Du Comb, W. & Burnett, A. L. Clinical outcomes of the Burnett \u201csnake\u201d maneuver shunt modification for ischemic priapism. J. Sex. Med. 21, 723\u2013728 (2024).","journal-title":"J. Sex. Med."},{"key":"1069_CR69","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jsxm.2019.05.011","volume":"16","author":"M Orta\u00e7","year":"2019","unstructured":"Orta\u00e7, M., \u00c7evik, G., Akdere, H., Erme\u00e7, B. & Kad\u0131o\u011flu, A. Anatomic and functional outcome following distal shunt and tunneling for treatment ischemic priapism: a single-center experience. J. Sex. Med. 16, 1290\u20131296 (2019).","journal-title":"J. Sex. Med."},{"key":"1069_CR70","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.juro.2013.07.034","volume":"191","author":"E Zacharakis","year":"2014","unstructured":"Zacharakis, E. et al. The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. J. Urol. 191, 164\u2013168 (2014).","journal-title":"J. Urol."},{"key":"1069_CR71","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jsxm.2018.02.010","volume":"15","author":"JS Fuchs","year":"2018","unstructured":"Fuchs, J. S. et al. Penoscrotal decompression-promising new treatment paradigm for refractory ischemic priapism. J. Sex. Med. 15, 797\u2013802 (2018).","journal-title":"J. Sex. Med."},{"key":"1069_CR72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bju.15127","volume":"126","author":"AS Baumgarten","year":"2020","unstructured":"Baumgarten, A. S. et al. Favourable multi-institutional experience with penoscrotal decompression for prolonged ischaemic priapism. BJU Int. 126, 441\u2013446 (2020).","journal-title":"BJU Int."},{"key":"1069_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41443-023-00808-z","volume":"36","author":"ME VanDyke","year":"2024","unstructured":"VanDyke, M. E. et al. Current opinions on the management of prolonged ischemic priapism: does penoscrotal decompression outperform corporoglanular tunneling? Int. J. Impot. Res. 36, 62\u201367 (2024).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR74","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jsxm.2020.07.013","volume":"17","author":"JJ Ramstein","year":"2020","unstructured":"Ramstein, J. J. et al. Clinical outcomes of periprocedural antithrombotic therapy in ischemic priapism management. J. Sex. Med. 17, 2260\u20132266 (2020).","journal-title":"J. Sex. Med."},{"key":"1069_CR75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.euf.2022.11.005","volume":"9","author":"A Muneer","year":"2023","unstructured":"Muneer, A. Insertion of penile implants in patients with priapism: when is the right time? Eur. Urol. Focus. 9, 49\u201350 (2023).","journal-title":"Eur. Urol. Focus."},{"key":"1069_CR76","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/bju.12686","volume":"114","author":"E Zacharakis","year":"2014","unstructured":"Zacharakis, E. et al. Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU Int. 114, 576\u2013581 (2014).","journal-title":"BJU Int."},{"key":"1069_CR77","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.euf.2019.01.009","volume":"5","author":"A Muneer","year":"2019","unstructured":"Muneer, A. & Ralph, D. J. Immediate placement of a penile prosthesis as first-line treatment for the management of ischaemic priapism. Eur. Urol. Focus. 5, 529\u2013530 (2019).","journal-title":"Eur. Urol. Focus."},{"key":"1069_CR78","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/sxmrev\/qeae007","volume":"12","author":"M Elmarasi","year":"2024","unstructured":"Elmarasi, M. et al. Early vs delayed insertion of penile prosthesis in patients with refractory priapism: a systematic review and meta-analysis. Sex. Med. Rev. 12, 528\u2013536 (2024).","journal-title":"Sex. Med. Rev."},{"key":"1069_CR79","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1046\/j.1464-410X.2002.03058.x","volume":"90","author":"RW Rees","year":"2002","unstructured":"Rees, R. W. et al. The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU Int. 90, 893\u2013897 (2002).","journal-title":"BJU Int."},{"key":"1069_CR80","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.juro.2010.02.014","volume":"183","author":"EA Salem","year":"2010","unstructured":"Salem, E. A. & El Aasser, O. Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion. J. Urol. 183, 2300\u20132303 (2010).","journal-title":"J. Urol."},{"key":"1069_CR81","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ijir.2011.23","volume":"23","author":"O Sedigh","year":"2011","unstructured":"Sedigh, O. et al. Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature. Int. J. Impot. Res. 23, 158\u2013164 (2011).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR82","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/2090598X.2022.2135290","volume":"21","author":"B Salman","year":"2022","unstructured":"Salman, B., Elsherif, E., Elgharabawy, M. & Badawy, A. Early versus delayed penile prosthesis insertion for refractory ischemic priapism. Arab. J. Urol. 21, 76\u201381 (2022).","journal-title":"Arab. J. Urol."},{"key":"1069_CR83","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3109\/21681805.2015.1059359","volume":"49","author":"E Zacharakis","year":"2015","unstructured":"Zacharakis, E. et al. Early insertion of a malleable penile prosthesis in ischaemic priapism allows later upsizing of the cylinders. Scand. J. Urol. 49, 468\u2013471 (2015).","journal-title":"Scand. J. Urol."},{"key":"1069_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12301-020-00114-w","volume":"27","author":"MM Elhawy","year":"2021","unstructured":"Elhawy, M. M. & Fawzy, A. M. Outcomes of low-flow priapism and role of integrated penile prosthesis management. Afr. J. Urol. 27, 1\u20138 (2021).","journal-title":"Afr. J. Urol."},{"key":"1069_CR85","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.eururo.2008.09.044","volume":"56","author":"DJ Ralph","year":"2009","unstructured":"Ralph, D. J. et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur. Urol. 56, 1033\u20131038 (2009).","journal-title":"Eur. Urol."},{"key":"1069_CR86","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bju.14859","volume":"125","author":"KL Hebert","year":"2020","unstructured":"Hebert, K. L., Yafi, F. A. & Wilson, S. Inflatable penile prosthesis implantation into scarred corporal bodies: timing may decrease postoperative problems. BJU Int. 125, 168\u2013172 (2020).","journal-title":"BJU Int."},{"key":"1069_CR87","doi-asserted-by":"publisher","first-page":"574","DOI":"10.21037\/tau-23-224","volume":"13","author":"DA Velasquez","year":"2024","unstructured":"Velasquez, D. A., Guimaraes, P. V. B., Lescay, H. & Raheem, O. Penile prosthesis in priapism: a systematic review of outcomes and complications. Transl. Androl. Urol. 13, 574\u2013583 (2024).","journal-title":"Transl. Androl. Urol."},{"key":"1069_CR88","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/jsxmed\/qdad075","volume":"20","author":"DW Barham","year":"2023","unstructured":"Barham, D. W. et al. Delayed placement of an inflatable penile prosthesis is associated with a high complication rate in men with a history of ischemic priapism. J. Sex. Med. 20, 1052\u20131056 (2023).","journal-title":"J. Sex. Med."},{"key":"1069_CR89","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jsxm.2016.11.304","volume":"14","author":"PN Tsambarlis","year":"2017","unstructured":"Tsambarlis, P. N., Chaus, F. & Levine, L. A. Successful placement of penile prostheses in men with severe corporal fibrosis following vacuum therapy protocol. J. Sex. Med. 14, 44\u201346 (2017).","journal-title":"J. Sex. Med."},{"key":"1069_CR90","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41443-022-00629-6","volume":"35","author":"N Schifano","year":"2023","unstructured":"Schifano, N., Capogrosso, P., Cakir, O. O., Deh\u00f2, F. & Garaffa, G. Surgical tips in difficult penile prosthetic surgery: a narrative review. Int. J. Impot. Res. 35, 690\u2013698 (2023).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR91","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41443-023-00787-1","volume":"35","author":"M Yassin","year":"2023","unstructured":"Yassin, M., Chen, R., Ager, M., Desouky, E. & Minhas, S. Penile implants in low flow priapism. Int. J. Impot. Res. 35, 651\u2013663 (2023).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1464-410X.2005.05907.x","volume":"97","author":"A Minervini","year":"2006","unstructured":"Minervini, A., Ralph, D. J. & Pryor, J. P. Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int. 97, 129\u2013133 (2006).","journal-title":"BJU Int."},{"key":"1069_CR93","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/smrj.8","volume":"1","author":"L Trost","year":"2013","unstructured":"Trost, L. & Hellstrom, W. J. G. History, contemporary outcomes, and future of penile prostheses: a review of the literature. Sex. Med. Rev. 1, 150\u2013163 (2013).","journal-title":"Sex. Med. Rev."},{"key":"1069_CR94","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.sxmr.2017.08.002","volume":"6","author":"\u00d6B Y\u00fccel","year":"2018","unstructured":"Y\u00fccel, \u00d6. B., Paz\u0131r, Y. & Kad\u0131o\u011flu, A. Penile prosthesis implantation in priapism. Sex. Med. Rev. 6, 310\u2013318 (2018).","journal-title":"Sex. Med. Rev."},{"key":"1069_CR95","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/sj.ijir.3901257","volume":"17","author":"R Kuefer","year":"2005","unstructured":"Kuefer, R. et al. Changing diagnostic and therapeutic concepts in high-flow priapism. Int. J. Impot. Res. 17, 109\u2013113 (2005).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41443-023-00719-z","volume":"36","author":"C von Stempel","year":"2024","unstructured":"von Stempel, C. et al. Therapeutic outcomes and analysis of Doppler findings in 25 patients with non-ischemic priapism. Int. J. Impot. Res. 36, 55\u201361 (2024).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR97","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0022-5347(17)39889-0","volume":"143","author":"MA Witt","year":"1990","unstructured":"Witt, M. A., Goldstein, I., Saenz de Tejada, I., Greenfield, A. & Krane, R. J. Traumatic laceration of intracavernosal arteries: the pathophysiology of nonischemic, high flow, arterial priapism. J. Urol. 143, 129\u2013132 (1990).","journal-title":"J. Urol."},{"key":"1069_CR98","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0022-5347(17)36017-2","volume":"149","author":"R Ricciardi","year":"1993","unstructured":"Ricciardi, R. et al. Delayed high flow priapism: pathophysiology and management. J. Urol. 149, 119\u2013121 (1993).","journal-title":"J. Urol."},{"key":"1069_CR99","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.sxmr.2019.03.004","volume":"8","author":"AR Ingram","year":"2020","unstructured":"Ingram, A. R., Stillings, S. A. & Jenkins, L. C. An update on non-ischemic priapism. Sex. Med. Rev. 8, 140\u2013149 (2020).","journal-title":"Sex. Med. Rev."},{"key":"1069_CR100","first-page":"109","volume":"1","author":"AK Wu","year":"2012","unstructured":"Wu, A. K. & Lue, T. F. Commentary on high flow, non-ischemic, priapism. Transl. Androl. Urol. 1, 109\u2013112 (2012).","journal-title":"Transl. Androl. Urol."},{"key":"1069_CR101","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/sc.2011.57","volume":"49","author":"NV Todd","year":"2011","unstructured":"Todd, N. V. Priapism in acute spinal cord injury. Spinal Cord 49, 1033\u20131035 (2011).","journal-title":"Spinal Cord"},{"key":"1069_CR102","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0090-4295(97)00607-9","volume":"51","author":"FM Dubocq","year":"1998","unstructured":"Dubocq, F. M., Tefilli, M. V., Grignon, D. J., Pontes, J. E. & Dhabuwala, C. B. High flow malignant priapism with isolated metastasis to the corpora cavernosa. Urology 51, 324\u2013326 (1998).","journal-title":"Urology"},{"key":"1069_CR103","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1097\/01.ju.0000116287.03211.8d","volume":"171","author":"AA Karagiannis","year":"2004","unstructured":"Karagiannis, A. A. et al. High flow priapism secondary to internal urethrotomy treated with embolization. J. Urol. 171, 1631\u20131632 (2004).","journal-title":"J. Urol."},{"key":"1069_CR104","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.ijir.3901251","volume":"17","author":"G Liguori","year":"2005","unstructured":"Liguori, G. et al. High-flow priapism (HFP) secondary to Nesbit operation: management by percutaneous embolization and colour Doppler-guided compression. Int. J. Impot. Res. 17, 304\u2013306 (2005).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2069-9","volume":"5","author":"M Tang","year":"2016","unstructured":"Tang, M. et al. Intracavernosal metaraminol bitartrate for treatment of priapism resulting from circumcision: a case report. Springerplus 5, 436 (2016).","journal-title":"Springerplus"},{"key":"1069_CR106","first-page":"1","volume":"2017","author":"NA Mistry","year":"2017","unstructured":"Mistry, N. A., Tadros, N. N. & Hedges, J. C. Conversion of low-flow priapism to high-flow state using T-shunt with tunneling. Case Rep. Urol. 2017, 1\u20134 (2017).","journal-title":"Case Rep. Urol."},{"key":"1069_CR107","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5301\/RU.2011.8491","volume":"78","author":"R Boscolo-Berto","year":"2011","unstructured":"Boscolo-Berto, R. et al. Determinism and liabilities in a complicated transrectal prostate biopsy: what is what. Urologia 78, 176\u2013179 (2011).","journal-title":"Urologia"},{"key":"1069_CR108","first-page":"605","volume":"62","author":"J Oshima","year":"2016","unstructured":"Oshima, J. et al. [Nonischemic priapism following brachytherapy: a case report and a review]. Hinyokika Kiyo 62, 605\u2013607 (2016).","journal-title":"Hinyokika Kiyo"},{"key":"1069_CR109","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/02841850802027026","volume":"49","author":"M Bertolotto","year":"2008","unstructured":"Bertolotto, M., Zappetti, R., Pizzolato, R. & Liguori, G. Color Doppler appearance of penile cavernosal-spongiosal communications in patients with high-flow priapism. Acta Radiol. 49, 710\u2013714 (2008).","journal-title":"Acta Radiol."},{"key":"1069_CR110","doi-asserted-by":"publisher","first-page":"16","DOI":"10.14366\/usg.17022","volume":"37","author":"DC Jung","year":"2018","unstructured":"Jung, D. C., Park, S. Y. & Lee, J. Y. Penile Doppler ultrasonography revisited. Ultrasonography 37, 16\u201324 (2018).","journal-title":"Ultrasonography"},{"key":"1069_CR111","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0009-9260(98)80195-5","volume":"53","author":"BC Kang","year":"1998","unstructured":"Kang, B. C. et al. Post-traumatic arterial priapism: colour Doppler examination and superselective arterial embolization. Clin. Radiol. 53, 830\u2013834 (1998).","journal-title":"Clin. Radiol."},{"key":"1069_CR112","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4081\/aiua.2015.3.258","volume":"87","author":"E Zacharakis","year":"2015","unstructured":"Zacharakis, E., Ralph, D. J., Walkden, M. & Muneer, A. Distal corpus cavernosum fibrosis and erectile dysfunction secondary to non-ischaemic priapism. Arch. Ital. Urol. Androl. 87, 258\u2013259 (2015).","journal-title":"Arch. Ital. Urol. Androl."},{"key":"1069_CR113","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/j.1743-6109.2010.01838.x","volume":"7","author":"KB Mwamukonda","year":"2010","unstructured":"Mwamukonda, K. B., Chi, T., Shindel, A. W. & Lue, T. F. Androgen blockade for the treatment of high-flow priapism. J. Sex. Med. 7, 2532\u20132537 (2010).","journal-title":"J. Sex. Med."},{"key":"1069_CR114","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1743-6109.2007.00560.x","volume":"5","author":"F Numan","year":"2008","unstructured":"Numan, F. et al. Posttraumatic nonischemic priapism treated with autologous blood clot embolization. J. Sex. Med. 5, 173\u2013179 (2008).","journal-title":"J. Sex. Med."},{"key":"1069_CR115","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jvir.2007.06.030","volume":"18","author":"KR Kim","year":"2007","unstructured":"Kim, K. R. et al. Treatment of high-flow priapism with superselective transcatheter embolization in 27 patients: a multicenter study. J. Vasc. Interv. Radiol. 18, 1222\u20131226 (2007).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"1069_CR116","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.urology.2008.01.087","volume":"72","author":"BX Liu","year":"2008","unstructured":"Liu, B. X. et al. High-flow priapism: superselective cavernous artery embolization with microcoils. Urology 72, 571\u2013573 (2008).","journal-title":"Urology"},{"key":"1069_CR117","doi-asserted-by":"publisher","first-page":"323","DOI":"10.21037\/qims.2016.06.02","volume":"6","author":"O Chevallier","year":"2016","unstructured":"Chevallier, O. et al. Ethylene-vinyl alcohol copolymer (Onyx\u00ae) transarterial embolization for post-traumatic high-flow priapism. Quant. Imaging Med. Surg. 6, 323\u2013327 (2016).","journal-title":"Quant. Imaging Med. Surg."},{"key":"1069_CR118","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/BF02577650","volume":"19","author":"F Numan","year":"1996","unstructured":"Numan, F. et al. Posttraumatic high-flow priapism treated by N-butyl-cyanoacrylate embolization. Cardiovasc. Interv. Radiol. 19, 278\u2013280 (1996).","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"1069_CR119","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00270-016-1356-8","volume":"39","author":"H Tokue","year":"2016","unstructured":"Tokue, H., Shibuya, K., Ueno, H., Tokue, A. & Tsushima, Y. Percutaneous direct puncture embolization with N-butyl-cyanoacrylate for high-flow priapism. Cardiovasc. Interv. Radiol. 39, 1343\u20131346 (2016).","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"1069_CR120","volume":"91","author":"A Arrichiello","year":"2020","unstructured":"Arrichiello, A. et al. Interventional radiology management of high flow priapism: review of the literature. Acta Biomed. 91, e2020010 (2020).","journal-title":"Acta Biomed."},{"key":"1069_CR121","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jsxmed\/qdaf010","volume":"22","author":"JP Bretzman","year":"2025","unstructured":"Bretzman, J. P., Ziegelmann, M. J. & Reisenauer, C. J. Selective penile artery angioembolization for high flow priapism \u2014 a step-by-step overview for the non-radiologist. J. Sex. Med. 22, 380\u2013384 (2025).","journal-title":"J. Sex. Med."},{"key":"1069_CR122","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0090-4295(97)00045-9","volume":"49","author":"RH Shapiro","year":"1997","unstructured":"Shapiro, R. H. & Berger, R. E. Post-traumatic priapism treated with selective cavernosal artery ligation. Urology 49, 638\u2013643 (1997).","journal-title":"Urology"},{"key":"1069_CR123","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2022.10233","volume":"328","author":"PL Kavanagh","year":"2022","unstructured":"Kavanagh, P. L., Fasipe, T. A. & Wun, T. Sickle cell disease: a review. JAMA 328, 57\u201368 (2022).","journal-title":"JAMA"},{"key":"1069_CR124","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/hematology.2022000380","volume":"2022","author":"IM Idris","year":"2022","unstructured":"Idris, I. M., Burnett, A. L. & DeBaun, M. R. Epidemiology and treatment of priapism in sickle cell disease. Hematol. Am. Soc. Hematol. Educ. Program. 2022, 450\u2013458 (2022).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"1069_CR125","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","volume":"10","author":"AM Thomson","year":"2023","unstructured":"Thomson, A. M. et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the global burden of disease study 2021. Lancet Haematol. 10, e585\u2013e599 (2023).","journal-title":"Lancet Haematol."},{"key":"1069_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1743-6109.2011.02288.x","volume":"9","author":"TJ Bivalacqua","year":"2012","unstructured":"Bivalacqua, T. J., Musicki, B., Kutlu, O. & Burnett, A. L. New insights into the pathophysiology of sickle cell disease-associated priapism. J. Sex. Med. 9, 79\u201387 (2012).","journal-title":"J. Sex. Med."},{"key":"1069_CR127","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","volume":"90","author":"AB Adeyoju","year":"2002","unstructured":"Adeyoju, A. B. et al. Priapism in sickle-cell disease; incidence, risk factors and complications \u2014 an international multicentre study. BJU Int. 90, 898\u2013902 (2002).","journal-title":"BJU Int."},{"key":"1069_CR128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jca.21394","volume":"31","author":"SK Ballas","year":"2016","unstructured":"Ballas, S. K. & Lyon, D. Safety and efficacy of blood exchange transfusion for priapism complicating sickle cell disease. J. Clin. Apher. 31, 5\u201310 (2016).","journal-title":"J. Clin. Apher."},{"key":"1069_CR129","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1401731","volume":"371","author":"MR DeBaun","year":"2014","unstructured":"DeBaun, M. R. et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N. Engl. J. Med. 371, 699\u2013710 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1069_CR130","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S0022-5347(17)35817-2","volume":"150","author":"JF Siegel","year":"1993","unstructured":"Siegel, J. F., Rich, M. A., Brock, W. A. & Noe, H. N. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J. Urol. 150, 1480\u20131482 (1993).","journal-title":"J. Urol."},{"key":"1069_CR131","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.juro.2012.06.015","volume":"188","author":"M Roizenblatt","year":"2012","unstructured":"Roizenblatt, M. et al. Priapism is associated with sleep hypoxemia in sickle cell disease. J. Urol. 188, 1245\u20131251 (2012).","journal-title":"J. Urol."},{"key":"1069_CR132","doi-asserted-by":"publisher","first-page":"743399","DOI":"10.3389\/fphys.2021.743399","volume":"12","author":"E Stauffer","year":"2021","unstructured":"Stauffer, E. et al. Nocturnal hypoxemia rather than obstructive sleep apnea is associated with decreased red blood cell deformability and enhanced hemolysis in patients with sickle cell disease. Front. Physiol. 12, 743399 (2021).","journal-title":"Front. Physiol."},{"key":"1069_CR133","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2164\/jandrol.110.010934","volume":"32","author":"AB Olujohungbe","year":"2011","unstructured":"Olujohungbe, A. B. et al. A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial-the priapism in sickle cell study. J. Androl. 32, 375\u2013382 (2011).","journal-title":"J. Androl."},{"key":"1069_CR134","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1046\/j.1365-2141.2002.03691.x","volume":"118","author":"I Okpala","year":"2002","unstructured":"Okpala, I., Westerdale, N., Jegede, T. & Cheung, B. Etilefrine for the prevention of priapism in adult sickle cell disease. Br. J. Haematol. 118, 918\u2013921 (2002).","journal-title":"Br. J. Haematol."},{"key":"1069_CR135","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/sj.ijir.3901180","volume":"16","author":"S Priyadarshi","year":"2004","unstructured":"Priyadarshi, S. Oral terbutaline in the management of pharmacologically induced prolonged erection. Int. J. Impot. Res. 16, 424\u2013426 (2004).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR136","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0090-4295(96)00027-1","volume":"47","author":"R Virag","year":"1996","unstructured":"Virag, R., Bachir, D., Lee, K. & Galacteros, F. Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology 47, 777\u2013781 (1996).","journal-title":"Urology"},{"key":"1069_CR137","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/01.ju.0000075500.11519.e8","volume":"170","author":"G Lin","year":"2003","unstructured":"Lin, G. et al. Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J. Urol. 170, S15\u20138 (2003).","journal-title":"J. Urol."},{"key":"1069_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068028","volume":"8","author":"TJ Bivalacqua","year":"2013","unstructured":"Bivalacqua, T. J. et al. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress. PLoS ONE 8, e68028 (2013).","journal-title":"PLoS ONE"},{"key":"1069_CR139","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1743-6109.2006.00333.x","volume":"3","author":"AL Burnett","year":"2006","unstructured":"Burnett, A. L., Bivalacqua, T. J., Champion, H. C. & Musicki, B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J. Sex. Med. 3, 1077\u20131084 (2006).","journal-title":"J. Sex. Med."},{"key":"1069_CR140","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","volume":"127","author":"AL Burnett","year":"2014","unstructured":"Burnett, A. L., Anele, U. A., Trueheart, I. N., Strouse, J. J. & Casella, J. F. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am. J. Med. 127, 664\u2013668 (2014).","journal-title":"Am. J. Med."},{"key":"1069_CR141","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/JU.0000000000001365","volume":"205","author":"LT Hou","year":"2021","unstructured":"Hou, L. T. & Burnett, A. L. Regimented phosphodiesterase type 5 inhibitor use reduces emergency department visits for recurrent ischemic priapism. J. Urol. 205, 545\u2013552 (2021).","journal-title":"J. Urol."},{"key":"1069_CR142","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/00005392-199805000-00033","volume":"159","author":"S Gupta","year":"1998","unstructured":"Gupta, S. et al. A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium\/potassium adenosine triphosphatase activity. J. Urol. 159, 1529\u20131536 (1998).","journal-title":"J. Urol."},{"key":"1069_CR143","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/S0022-5347(05)64201-2","volume":"168","author":"KF Rourke","year":"2002","unstructured":"Rourke, K. F., Fischler, A. H. & Jordan, G. H. Treatment of recurrent idiopathic priapism with oral baclofen. J. Urol. 168, 2552\u20132553 (2002).","journal-title":"J. Urol."},{"key":"1069_CR144","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1745-7262.2008.00314.x","volume":"10","author":"J Yuan","year":"2008","unstructured":"Yuan, J., Desouza, R., Westney, O. L. & Wang, R. Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J. Androl. 10, 88\u2013101 (2008).","journal-title":"Asian J. Androl."},{"key":"1069_CR145","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/sj.ijir.3901165","volume":"16","author":"P Perimenis","year":"2004","unstructured":"Perimenis, P., Athanasopoulos, A., Papathanasopoulos, P. & Barbalias, G. Gabapentin in the management of the recurrent, refractory, idiopathic priapism. Int. J. Impot. Res. 16, 84\u201385 (2004).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR146","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0022-5347(17)35520-9","volume":"150","author":"LA Levine","year":"1993","unstructured":"Levine, L. A. & Guss, S. P. Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J. Urol. 150, 475\u2013477 (1993).","journal-title":"J. Urol."},{"key":"1069_CR147","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/00005392-199501000-00054","volume":"153","author":"J Steinberg","year":"1995","unstructured":"Steinberg, J. & Eyre, R. C. Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue. J. Urol. 153, 152\u2013153 (1995).","journal-title":"J. Urol."},{"key":"1069_CR148","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0090-4295(01)01492-3","volume":"59","author":"P Dahm","year":"2002","unstructured":"Dahm, P., Rao, D. S. & Donatucci, C. F. Antiandrogens in the treatment of priapism. Urology 59, 138 (2002).","journal-title":"Urology"},{"key":"1069_CR149","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.urology.2004.02.005","volume":"63","author":"N Yamashita","year":"2004","unstructured":"Yamashita, N. et al. Idiopathic stuttering priapism: recovery of detumescence mechanism with temporal use of antiandrogen. Urology 63, 1182\u20131184 (2004).","journal-title":"Urology"},{"key":"1069_CR150","first-page":"167","volume":"4","author":"R Costabile","year":"1998","unstructured":"Costabile, R. Successful treatment of stutter priapism with an antiandrogen. Tech. Urol. 4, 167\u2013168 (1998).","journal-title":"Tech. Urol."},{"key":"1069_CR151","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/humrep\/dem379","volume":"23","author":"S Franks","year":"2008","unstructured":"Franks, S., Layton, A. & Glasier, A. Cyproterone acetate\/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy. Hum. Reprod. 23, 231\u2013232 (2008).","journal-title":"Hum. Reprod."},{"key":"1069_CR152","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.eururo.2003.11.016","volume":"45","author":"FH Schr\u00f6der","year":"2004","unstructured":"Schr\u00f6der, F. H. et al. Metastatic prostate cancer treated by flutamide versus cyproterone acetate: final analysis of the \u201cEuropean Organization for Research and Treatment of Cancer\u201d (EORTC) protocol 30892. Eur. Urol. 45, 457\u2013464 (2004).","journal-title":"Eur. Urol."},{"key":"1069_CR153","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0010-440X(81)90034-1","volume":"22","author":"AJ Cooper","year":"1981","unstructured":"Cooper, A. J. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr. Psychiatry 22, 458\u2013465 (1981).","journal-title":"Compr. Psychiatry"},{"key":"1069_CR154","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.juro.2008.01.039","volume":"179","author":"BJ DeCastro","year":"2008","unstructured":"DeCastro, B. J., Costabile, R. A., McMann, L. P. & Peterson, A. C. Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial. J. Urol. 179, 1930\u20131932 (2008).","journal-title":"J. Urol."},{"key":"1069_CR155","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jsm.12359","volume":"11","author":"MP Hoeh","year":"2014","unstructured":"Hoeh, M. P. & Levine, L. A. Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. J. Sex. Med. 11, 197\u2013204 (2014).","journal-title":"J. Sex. Med."},{"key":"1069_CR156","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.urology.2009.04.071","volume":"74","author":"D Rachid-Filho","year":"2009","unstructured":"Rachid-Filho, D., Cavalcanti, A. G., Favorito, L. A., Costa, W. S. & Sampaio, F. J. B. Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach. Urology 74, 1054\u20131057 (2009).","journal-title":"Urology"},{"key":"1069_CR157","doi-asserted-by":"publisher","first-page":"87","DOI":"10.21037\/tau.2019.07.15","volume":"9","author":"RC Baker","year":"2020","unstructured":"Baker, R. C., Bergeson, R. L., Yi, Y. A., Ward, E. E. & Morey, A. F. Dutasteride in the long-term management of stuttering priapism. Transl. Androl. Urol. 9, 87\u201392 (2020).","journal-title":"Transl. Androl. Urol."},{"key":"1069_CR158","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","volume":"2","author":"GR Serjeant","year":"1985","unstructured":"Serjeant, G. R., De Ceulaer, K. & Maude, G. H. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 2, 1274\u20131276 (1985).","journal-title":"Lancet"},{"key":"1069_CR159","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s11255-014-0737-7","volume":"46","author":"UA Anele","year":"2014","unstructured":"Anele, U. A., Mack, A. K., Resar, L. M. S. & Burnett, A. L. Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature. Int. Urol. Nephrol. 46, 1733\u20131736 (2014).","journal-title":"Int. Urol. Nephrol."},{"key":"1069_CR160","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1097\/00005392-199805000-00065","volume":"159","author":"A Hassan","year":"1998","unstructured":"Hassan, A., Jam\u2019a, A. & Al Dabbous, I. A. Hydroxyurea in the treatment of sickle cell associated priapism. J. Urol. 159, 1642 (1998).","journal-title":"J. Urol."},{"key":"1069_CR161","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ajh.20142","volume":"77","author":"STO Saad","year":"2004","unstructured":"Saad, S. T. O. et al. Follow-up of sickle cell disease patients with priapism treated by hydroxyurea. Am. J. Hematol. 77, 45\u201349 (2004).","journal-title":"Am. J. Hematol."},{"key":"1069_CR162","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2017","unstructured":"Ataga, K. I. et al. Crizanlizumab for the prevention of pain crises in sickle cell disease. N. Engl. J. Med. 376, 429\u2013439 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1069_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8585","volume":"12","author":"M Abdulgayoom","year":"2024","unstructured":"Abdulgayoom, M., Afana, M. S., Alshurafa, A. & Yassin, M. A. Potential efficacy of crizanlizumab in treating priapism in sickle cell disease: a case report. Clin. Case Rep. 12, e8585 (2024).","journal-title":"Clin. Case Rep."},{"key":"1069_CR164","doi-asserted-by":"publisher","first-page":"232470962311918","DOI":"10.1177\/23247096231191873","volume":"11","author":"M Idowu","year":"2023","unstructured":"Idowu, M., Garcia, R. L. & Sule, O. B. Successful treatment of SCD-related priapism with crizanlizumab: a case series. J. Investig. Med. High. Impact Case Rep. 11, 23247096231191873 (2023).","journal-title":"J. Investig. Med. High. Impact Case Rep."},{"key":"1069_CR165","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1182\/blood-2023-179042","volume":"142","author":"M Idowu","year":"2023","unstructured":"Idowu, M. et al. Primary analysis of spartan: a phase 2 trial to assess the efficacy and safety of crizanlizumab in patients with sickle cell disease related priapism. Blood 142, 146\u2013146 (2023).","journal-title":"Blood"},{"key":"1069_CR166","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/S0022-5347(01)63590-0","volume":"159","author":"A Seftel","year":"1998","unstructured":"Seftel, A. et al. High flow priapism complicating veno-occlusive priapism: pathophysiology of recurrent idiopathic priapism? J. Urol. 159, 1300\u20131301 (1998).","journal-title":"J. Urol."},{"key":"1069_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s12610-019-0095-5","volume":"29","author":"M Abdessater","year":"2019","unstructured":"Abdessater, M. et al. Sleep related painful erection: an algorithm for evaluation and management. Basic. Clin. Androl. 29, 15 (2019).","journal-title":"Basic. Clin. Androl."},{"key":"1069_CR168","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41585-023-00803-5","volume":"21","author":"M G\u00fcl","year":"2024","unstructured":"G\u00fcl, M. et al. A clinical guide to rare male sexual disorders. Nat. Rev. Urol. 21, 35\u201349 (2024).","journal-title":"Nat. Rev. Urol."},{"key":"1069_CR169","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s13311-012-0143-8","volume":"9","author":"MJ Howell","year":"2012","unstructured":"Howell, M. J. Parasomnias: an updated review. Neurotherapeutics 9, 753\u2013775 (2012).","journal-title":"Neurotherapeutics"},{"key":"1069_CR170","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/j.esxm.2017.09.001","volume":"5","author":"S Vreugdenhil","year":"2017","unstructured":"Vreugdenhil, S., Weidenaar, A. C., de Jong, I. J. & van Driel, M. F. Sleep-related painful erections \u2014 a case series of 24 patients regarding diagnostics and treatment options. Sex. Med. 5, e237\u2013e243 (2017).","journal-title":"Sex. Med."},{"key":"1069_CR171","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jsxm.2017.11.006","volume":"15","author":"S Vreugdenhil","year":"2018","unstructured":"Vreugdenhil, S., Weidenaar, A. C., de Jong, I. J. & van Driel, M. F. Sleep-related painful erections: a meta-analysis on the pathophysiology and risks and benefits of medical treatments. J. Sex. Med. 15, 5\u201319 (2018).","journal-title":"J. Sex. Med."},{"key":"1069_CR172","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.21037\/tau-21-1045","volume":"10","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Zhang, J. & Li, H. Narrative review: pathogenesis, diagnosis, and treatment of sleep-related painful erection. Transl. Androl. Urol. 10, 4422\u20134430 (2021).","journal-title":"Transl. Androl. Urol."},{"key":"1069_CR173","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41443-021-00462-3","volume":"34","author":"M Johnson","year":"2022","unstructured":"Johnson, M. et al. Differences in polysomnographic, nocturnal penile tumescence and penile doppler ultrasound findings in men with stuttering priapism and sleep-related painful erections. Int. J. Impot. Res. 34, 603\u2013609 (2022).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR174","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jsxm.2020.11.010","volume":"18","author":"MJ Johnson","year":"2021","unstructured":"Johnson, M. J., McNeillis, V., Chiriaco, G. & Ralph, D. J. Rare disorders of painful erection: a cohort study of the investigation and management of stuttering priapism and sleep-related painful erection. J. Sex. Med. 18, 376\u2013384 (2021).","journal-title":"J. Sex. Med."},{"key":"1069_CR175","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-024-02909-8","volume":"30","author":"NL Crossnohere","year":"2024","unstructured":"Crossnohere, N. L. et al. A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide. Nat. Med. 30, 1519\u20131520 (2024).","journal-title":"Nat. Med."},{"key":"1069_CR176","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.urology.2015.02.025","volume":"85","author":"AL Burnett","year":"2015","unstructured":"Burnett, A. L., Anele, U. A. & Derogatis, L. R. Priapism impact profile questionnaire: development and initial validation. Urology 85, 1376\u20131381 (2015).","journal-title":"Urology"},{"key":"1069_CR177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258560","volume":"16","author":"BF Morrison","year":"2021","unstructured":"Morrison, B. F. et al. External validation of the priapism impact profile in a Jamaican cohort of patients with sickle cell disease. PLoS ONE 16, e0258560 (2021).","journal-title":"PLoS ONE"},{"key":"1069_CR178","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.eururo.2016.05.050","volume":"71","author":"Z Lu","year":"2017","unstructured":"Lu, Z. et al. Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis. Eur. Urol. 71, 223\u2013233 (2017).","journal-title":"Eur. Urol."},{"key":"1069_CR179","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsxm.2016.11.001","volume":"14","author":"RI Clavijo","year":"2017","unstructured":"Clavijo, R. I., Kohn, T. P., Kohn, J. R. & Ramasamy, R. Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: a systematic review and meta-analysis. J. Sex. Med. 14, 27\u201335 (2017).","journal-title":"J. Sex. Med."},{"key":"1069_CR180","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41443-021-00429-4","volume":"34","author":"A Cocci","year":"2022","unstructured":"Cocci, A. et al. Low-intensity extracorporeal shock wave therapy (Li-ESWT) for priapism-induced erectile dysfunction in young patients: the first case series. Int. J. Impot. Res. 34, 277\u2013279 (2022).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR181","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MOU.0000000000000636","volume":"29","author":"E Pozzi","year":"2019","unstructured":"Pozzi, E. et al. Stem-cell regenerative medicine as applied to the penis. Curr. Opin. Urol. 29, 443\u2013449 (2019).","journal-title":"Curr. Opin. Urol."},{"key":"1069_CR182","doi-asserted-by":"publisher","first-page":"qfad071","DOI":"10.1093\/sexmed\/qfad071","volume":"12","author":"C Manfredi","year":"2024","unstructured":"Manfredi, C. et al. Cell therapy for male sexual dysfunctions: systematic review and position statements from the European Society for Sexual Medicine. Sex. Med. 12, qfad071 (2024).","journal-title":"Sex. Med."},{"key":"1069_CR183","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.euf.2022.11.009","volume":"9","author":"F Castiglione","year":"2023","unstructured":"Castiglione, F., Cakir, O. O., Satchi, M., Fallara, G. & Pang, K. H. The current role and implications of stem cell therapy in erectile dysfunction: a transformation from caterpillar to butterfly is required. Eur. Urol. Focus. 9, 28\u201331 (2023).","journal-title":"Eur. Urol. Focus."},{"key":"1069_CR184","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/sxmrev\/qeae018","volume":"12","author":"M Deabes","year":"2024","unstructured":"Deabes, M. et al. Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials. Sex. Med. Rev. 12, 739\u2013746 (2024).","journal-title":"Sex. Med. Rev."},{"key":"1069_CR185","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41443-023-00798-y","volume":"36","author":"A Panunzio","year":"2024","unstructured":"Panunzio, A. et al. Platelet-rich plasma intracavernosal injections for the treatment of primary organic erectile dysfunction: a systematic review and meta-analysis of contemporary controlled studies. Int. J. Impot. Res. 36, 562\u2013571 (2024).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR186","doi-asserted-by":"publisher","first-page":"qfaf034","DOI":"10.1093\/sexmed\/qfaf034","volume":"13","author":"KH Pang","year":"2025","unstructured":"Pang, K. H. The effectiveness and safety of intracavernosal botulinum toxin injections in the management of erectile dysfunction: a systematic review and meta-analysis of clinical studies. Sex. Med. 13, qfaf034 (2025).","journal-title":"Sex. Med."},{"key":"1069_CR187","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/j.1743-6109.2010.01790.x","volume":"7","author":"AW Shindel","year":"2010","unstructured":"Shindel, A. W. et al. Pentoxifylline attenuates transforming growth factor-\u03b21-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. J. Sex. Med. 7, 2077 (2010).","journal-title":"J. Sex. Med."},{"key":"1069_CR188","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.eururo.2010.10.034","volume":"59","author":"M Albersen","year":"2011","unstructured":"Albersen, M. et al. Pentoxifylline promotes recovery of erectile function in a rat model of postprostatectomy erectile dysfunction. Eur. Urol. 59, 286\u2013296 (2011).","journal-title":"Eur. Urol."},{"key":"1069_CR189","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s11255-014-0769-z","volume":"46","author":"F Erdemir","year":"2014","unstructured":"Erdemir, F. et al. The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model. Int. Urol. Nephrol. 46, 1961\u20131967 (2014).","journal-title":"Int. Urol. Nephrol."},{"key":"1069_CR190","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41443-019-0152-9","volume":"32","author":"O Cinar","year":"2020","unstructured":"Cinar, O. et al. The effect of an antifibrotic agent, pirfenidone, on penile erectile function in an experimental rat model of ischemic priapism. Int. J. Impot. Res. 32, 232\u2013238 (2020).","journal-title":"Int. J. Impot. Res."},{"key":"1069_CR191","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1096\/fj.13-228817","volume":"28","author":"G Lagoda","year":"2014","unstructured":"Lagoda, G. et al. Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J. 28, 76\u201384 (2014).","journal-title":"FASEB J."},{"key":"1069_CR192","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/andr.13599","volume":"12","author":"DA Pereira","year":"2024","unstructured":"Pereira, D. A. et al. Heme-induced corpus cavernosum relaxation and its implications for priapism in sickle cell disease: a mechanistic insight. Andrology 12, 1857\u20131864 (2024).","journal-title":"Andrology"},{"key":"1069_CR193","doi-asserted-by":"publisher","first-page":"1435220","DOI":"10.3389\/fphys.2024.1435220","volume":"15","author":"THR Silveira","year":"2024","unstructured":"Silveira, T. H. R., Calmasini, F. B., de Oliveira, M. G., Costa, F. F. & Silva, F. H. Targeting heme in sickle cell disease: new perspectives on priapism treatment. Front. Physiol. 15, 1435220 (2024).","journal-title":"Front. Physiol."},{"key":"1069_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/S41443-024-00849-Y","author":"MG Asmundo","year":"2024","unstructured":"Asmundo, M. G. & Russo, G. I. ManAgement of pRiapiSm and its impact on outcomes: an international register (MARS study) \u2014 the first international, multicenter, observational study regarding priapism in perspective. Int. J. Impot. Res. https:\/\/doi.org\/10.1038\/S41443-024-00849-Y (2024).","journal-title":"Int. J. Impot. Res."}],"updated-by":[{"DOI":"10.1038\/s41585-026-01166-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000}}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01069-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:02:15Z","timestamp":1781024535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01069-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":194,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-01069-9","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"7 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41585-026-01166-3","URL":"https:\/\/doi.org\/10.1038\/s41585-026-01166-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}